As usual at BIO-Europe, the fair starts with an opening keynote, this time with speakers from Merck Healthcare, MedImmune/AstraZeneca and Baxalta.
The keynote is basically a discussion between high-level speakers, akin to the talk which took place in Paris during March, when Antoine Papiernik (the prominent European VC from Sofinnova) led a panel discussion with a few other CEOs.
This year, the panel had a pretty high level of Biotech clout again, even if the selection of speakers was more oriented towards Big Pharmas than Biotech. I’ll let you judge:
Edwards introduced the discussion :
“This will not be a panel discussion like the Republican ones, where none of the questions were answered“
That got me excited. I thought: Great! We will have a real discussion without formal or politically correct declarations. Unfortunately, it didn’t hold true to its promise, but the discussion was still interesting…